Tet2 Downregulation Promotes Aml Cell Proliferation Via Pim-1 Expression

Qingxiao Chen,Jingsong He,Xing Guo,Jing Chen,Xuanru Lin,Xi Huang,Haimeng Yan,Li Yang,Yi Li,Enfan Zhang,Yang,He Huang,Zhen Cai

DOI: https://doi.org/10.1182/blood.v128.22.5085.5085

IF: 20.3

2016-01-01

Blood

Abstract:Background: Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults which is still incurable although novel drugs and new combination of chemotherapies are used . With the development of genetic and molecular biology technologies, more and more genes are found to be related to leukemogenesis and drug resistance of AML. TET2, a member of the ten-eleven-translocation gene family which can modify DNA by catalyzing the conversion of 5-mehtyl-cytosine to 5-hydroxymethyl-cytosine , is often inactivated through mutation or deletion in myeloid malignancies. Recent research reported that TET2 knock-down can promote proliferation of hematopoietic stem cells and leukemic cells. Also, several clinical studies showed that patients with TET2 mutation or low levels of TET2 expression have more aggressive disease courses than those with normal levels of TET2. However, the mechanism of the phenomenon is unknown. Our aim is to uncover how TET2 protein level is negatively correlated with AML cell proliferation and to provide a better view of target therapy in AML.